Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.82 HKD | -2.62% | -5.56% | -0.38% |
Mar. 28 | Aim Vaccine Submits Pre-Applications for Clinical Trials for Two Vaccines; Shares Up 3% | MT |
Mar. 28 | Aim Vaccine's Loss Quadruples in 2023 as Revenue Slips 6%; Shares Up 3% | MT |
Sales 2024 * | 3.41B 471M 3.67B | Sales 2025 * | 4.67B 646M 5.04B | Capitalization | 9B 1.24B 9.71B |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 2.91 x |
Net Debt 2024 * | 904M 125M 975M | Net Debt 2025 * | 575M 79.53M 620M | EV / Sales 2025 * | 2.05 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 1,624 |
Yield 2024 * |
1.71% | Yield 2025 * |
3.25% | Free-Float | 22.09% |
1 day | -2.62% | ||
1 week | -5.56% | ||
Current month | -7.35% | ||
1 month | -6.12% | ||
3 months | +19.57% | ||
6 months | -15.82% | ||
Current year | -0.38% |
Managers | Title | Age | Since |
---|---|---|---|
Yan Zhou
CEO | Chief Executive Officer | 58 | 15-04-30 |
Wen Guan
PSD | President | 57 | 16-11-30 |
Li Xin Niu
DFI | Director of Finance/CFO | 52 | 15-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ker Wei Pei
BRD | Director/Board Member | 67 | 20-09-18 |
Xin Zhou
BRD | Director/Board Member | 55 | 13-04-30 |
Yan Zhou
CEO | Chief Executive Officer | 58 | 15-04-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-20 | 7.82 | -2.62% | 364 600 |
24-05-17 | 8.03 | 0.00% | 320,200 |
24-05-16 | 8.03 | -4.29% | 425,600 |
24-05-14 | 8.39 | +1.33% | 462,600 |
24-05-13 | 8.28 | +0.73% | 199,600 |
Delayed Quote Hong Kong S.E., May 20, 2024 at 04:08 am EDT
More quotesChiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-0.38% | 1.25B | |
-3.05% | 90.45B | |
+3.68% | 41.45B | |
-10.90% | 33.57B | |
+60.20% | 25.73B | |
-19.56% | 14.73B | |
-9.06% | 12.82B | |
-11.34% | 11.7B | |
-43.53% | 11.44B | |
+5.39% | 8.79B |
- Stock Market
- Equities
- 6660 Stock